Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues

por Vincent-Salomon, A, Bidard, F C, Pierga, J Y
Publicado 2008

The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells

por Tran Quang, C, Leboucher, S, Passaro, D, Fuhrmann, L, Nourieh, M, Vincent-Salomon, A, Ghysdael, J
Publicado en Cell Death Dis (2015)

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

por Pierga, J-Y, Bonneton, C, Magdelénat, H, Vincent-Salomon, A, Nos, C, Pouillart, P, Thiery, J-P
Publicado 2003

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

por Lefort, S, Thuleau, A, Kieffer, Y, Sirven, P, Bieche, I, Marangoni, E, Vincent-Salomon, A, Mechta-Grigoriou, F
Publicado en Oncogene (2017)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

por Rossi, L, Laas, E, Mallon, P, Vincent-Salomon, A, Guinebretiere, J-M, Lerebours, F, Rouzier, R, Pierga, J-Y, Reyal, F
Publicado en Br J Cancer (2015)

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?

por Sigal-Zafrani, B, Bollet, M A, Antoni, G, Savignoni, A, Vincent-Salomon, A, Pierga, J-Y, Salmon, R, Sastre-Garau, X, Fourquet, A
Publicado 2007

Low expression of bcl-2 in Brca1-associated breast cancers

por Freneaux, P, Stoppa-Lyonnet, D, Mouret, E, Kambouchner, M, Nicolas, A, Zafrani, B, Vincent-Salomon, A, Fourquet, A, Magdelenat, H, Sastre-Garau, X
Publicado 2000

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer

por Arnould, L, Denoux, Y, MacGrogan, G, Penault-Llorca, F, Fiche, M, Treilleux, I, Mathieu, M C, Vincent-Salomon, A, Vilain, M O, Couturier, J
Publicado 2003

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

por Pierga, J-Y, Mouret, E, Diéras, V, Laurence, V, Beuzeboc, P, Dorval, T, Palangié, T, Jouve, M, Vincent-Salomon, A, Scholl, S, Extra, J-M, Asselain, B, Pouillart, P
Publicado 2000

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

por Mouttet, D., Laé, M., Caly, M., Gentien, D., Carpentier, S., Peyro-Saint-Paul, H., Vincent-Salomon, A., Rouzier, R., Sigal-Zafrani, B., Sastre-Garau, X., Reyal, F.
Publicado en PLoS One (2016)

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

por Bollet, M A, Savignoni, A, Pierga, J-Y, Lae, M, Fourchotte, V, Kirova, Y M, Dendale, R, Campana, F, Sigal-Zafrani, B, Salmon, R, Fourquet, A, Vincent-Salomon, A
Publicado 2008

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

por Vincent-Salomon, A, Pierga, J-Y, Couturier, J, d'Enghien, C D, Nos, C, Sigal-Zafrani, B, Lae, M, Fréneaux, P, Diéras, V, Thiéry, J-P, Sastre-Garau, X
Publicado 2007

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer

por Faucheux, L., Grandclaudon, M., Perrot-Dockès, M., Sirven, P., Berger, F., Hamy, A.S., Fourchotte, V., Vincent-Salomon, A., Mechta-Grigoriou, F., Reyal, F., Scholer-Dahirel, A., Guillot-Delost, M., Soumelis, V.
Publicado en Oncoimmunology (2019)

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

por Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Publicado 2014

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

por de Plater, L, Laugé, A, Guyader, C, Poupon, M-F, Assayag, F, de Cremoux, P, Vincent-Salomon, A, Stoppa-Lyonnet, D, Sigal-Zafrani, B, Fontaine, J-J, Brough, R, Lord, C J, Ashworth, A, Cottu, P, Decaudin, D, Marangoni, E
Publicado 2010

Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the...

por Le Tourneau, C, Paoletti, X, Servant, N, Bièche, I, Gentien, D, Rio Frio, T, Vincent-Salomon, A, Servois, V, Romejon, J, Mariani, O, Bernard, V, Huppe, P, Pierron, G, Mulot, F, Callens, C, Wong, J, Mauborgne, C, Rouleau, E, Reyes, C, Henry, E, Leroy, Q, Gestraud, P, La Rosa, P, Escalup, L, Mitry, E, Trédan, O, Delord, J-P, Campone, M, Goncalves, A, Isambert, N, Gavoille, C, Kamal, M
Publicado 2014